Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04547062
Title Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML) (Tocilam)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nantes University Hospital
Indications

acute myeloid leukemia

Therapies

Tocilizumab

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.